These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29867511)

  • 41. Activation of the Nrf2-ARE Pathway Ameliorates Hyperglycemia-Mediated Mitochondrial Dysfunction in Podocytes Partly Through Sirt1.
    Zhang Q; Deng Q; Zhang J; Ke J; Zhu Y; Wen RW; Ye Z; Peng H; Su ZZ; Wang C; Lou T
    Cell Physiol Biochem; 2018; 48(1):1-15. PubMed ID: 29996125
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Betanin, isolated from fruits of Opuntia elatior Mill attenuates renal fibrosis in diabetic rats through regulating oxidative stress and TGF-β pathway.
    Sutariya B; Saraf M
    J Ethnopharmacol; 2017 Feb; 198():432-443. PubMed ID: 28111218
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High glucose up-regulates microRNA-34a-5p to aggravate fibrosis by targeting SIRT1 in HK-2 cells.
    Xue M; Li Y; Hu F; Jia YJ; Zheng ZJ; Wang L; Xue YM
    Biochem Biophys Res Commun; 2018 Mar; 498(1):38-44. PubMed ID: 29371016
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sirt1 activation prevents anti-Thy 1.1 mesangial proliferative glomerulonephritis in the rat through the Nrf2/ARE pathway.
    Huang K; Li R; Wei W
    Eur J Pharmacol; 2018 Aug; 832():138-144. PubMed ID: 29782856
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TGR5 activation suppressed S1P/S1P2 signaling and resisted high glucose-induced fibrosis in glomerular mesangial cells.
    Yang Z; Xiong F; Wang Y; Gong W; Huang J; Chen C; Liu P; Huang H
    Pharmacol Res; 2016 Sep; 111():226-236. PubMed ID: 27317945
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Berberine attenuates high glucose-induced fibrosis by activating the G protein-coupled bile acid receptor TGR5 and repressing the S1P2/MAPK signaling pathway in glomerular mesangial cells.
    Yang Z; Li J; Xiong F; Huang J; Chen C; Liu P; Huang H
    Exp Cell Res; 2016 Aug; 346(2):241-7. PubMed ID: 27292312
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epigallocatechin gallate upregulates NRF2 to prevent diabetic nephropathy via disabling KEAP1.
    Sun W; Liu X; Zhang H; Song Y; Li T; Liu X; Liu Y; Guo L; Wang F; Yang T; Guo W; Wu J; Jin H; Wu H
    Free Radic Biol Med; 2017 Jul; 108():840-857. PubMed ID: 28457936
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Limonin ameliorates acetaminophen-induced hepatotoxicity by activating Nrf2 antioxidative pathway and inhibiting NF-κB inflammatory response via upregulating Sirt1.
    Yang R; Song C; Chen J; Zhou L; Jiang X; Cao X; Sun Y; Zhang Q
    Phytomedicine; 2020 Apr; 69():153211. PubMed ID: 32259676
    [TBL] [Abstract][Full Text] [Related]  

  • 49. NLRP3 deficiency ameliorates renal inflammation and fibrosis in diabetic mice.
    Wu M; Han W; Song S; Du Y; Liu C; Chen N; Wu H; Shi Y; Duan H
    Mol Cell Endocrinol; 2018 Dec; 478():115-125. PubMed ID: 30098377
    [TBL] [Abstract][Full Text] [Related]  

  • 50. C66 ameliorates diabetic nephropathy in mice by both upregulating NRF2 function via increase in miR-200a and inhibiting miR-21.
    Wu H; Kong L; Tan Y; Epstein PN; Zeng J; Gu J; Liang G; Kong M; Chen X; Miao L; Cai L
    Diabetologia; 2016 Jul; 59(7):1558-1568. PubMed ID: 27115417
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quercetin inhibited mesangial cell proliferation of early diabetic nephropathy through the Hippo pathway.
    Lei D; Chengcheng L; Xuan Q; Yibing C; Lei W; Hao Y; Xizhi L; Yuan L; Xiaoxing Y; Qian L
    Pharmacol Res; 2019 Aug; 146():104320. PubMed ID: 31220559
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Study on the inhibitive effect of Catalpol on diabetic nephropathy.
    Chen J; Yang Y; Lv Z; Shu A; Du Q; Wang W; Chen Y; Xu H
    Life Sci; 2020 Sep; 257():118120. PubMed ID: 32693244
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Activation of GSK3β/β-TrCP axis via PHLPP1 exacerbates Nrf2 degradation leading to impairment in cell survival pathway during diabetic nephropathy.
    Mathur A; Pandey VK; Kakkar P
    Free Radic Biol Med; 2018 May; 120():414-424. PubMed ID: 29655866
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Daphnetin inhibits high glucose-induced extracellular matrix accumulation, oxidative stress and inflammation in human glomerular mesangial cells.
    Xu K; Guo L; Bu H; Wang H
    J Pharmacol Sci; 2019 Feb; 139(2):91-97. PubMed ID: 30595336
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Huangkui capsule attenuates renal fibrosis in diabetic nephropathy rats through regulating oxidative stress and p38MAPK/Akt pathways, compared to α-lipoic acid.
    Mao ZM; Shen SM; Wan YG; Sun W; Chen HL; Huang MM; Yang JJ; Wu W; Tang HT; Tang RM
    J Ethnopharmacol; 2015 Sep; 173():256-65. PubMed ID: 26226437
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structured DAG oil ameliorates renal injury in streptozotocin-induced diabetic rats through inhibition of NF-κB and activation of Nrf2 pathway.
    Das K; Ghosh M
    Food Chem Toxicol; 2017 Feb; 100():225-238. PubMed ID: 28025123
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Natural Rotenoid Deguelin Ameliorates Diabetic Neuropathy by Decreasing Oxidative Stress and Plasma Glucose Levels in Rats via the Nrf2 Signalling Pathway.
    Chen J; Liu W; Yi H; Hu X; Peng L; Yang F
    Cell Physiol Biochem; 2018; 48(3):1164-1176. PubMed ID: 30045011
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endogenous Nampt upregulation is associated with diabetic nephropathy inflammatory-fibrosis through the NF-κB p65 and Sirt1 pathway; NMN alleviates diabetic nephropathy inflammatory-fibrosis by inhibiting endogenous Nampt.
    Chen Y; Liang Y; Hu T; Wei R; Cai C; Wang P; Wang L; Qiao W; Feng L
    Exp Ther Med; 2017 Nov; 14(5):4181-4193. PubMed ID: 29104634
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protein kinase CK2α catalytic subunit ameliorates diabetic renal inflammatory fibrosis via NF-κB signaling pathway.
    Huang J; Chen Z; Li J; Chen Q; Li J; Gong W; Huang J; Liu P; Huang H
    Biochem Pharmacol; 2017 May; 132():102-117. PubMed ID: 28237649
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    Cheng Y; Liu C; Cui Y; Lv T; Guo Y; Liang J; Qian H
    RSC Adv; 2019 Mar; 9(15):8394-8403. PubMed ID: 35518685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.